| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
|
| [2] |
Dy GW, Gore JL, Forouzanfar MH, et al. Global burden of urologic cancers, 1990-2013[J]. Eur Urol, 2017, 71(3): 437-446. DOI: 10.1016/j.eururo.2016.10.008.
|
| [3] |
Lenis AT, Lec PM, Chamie K, et al. Bladder cancer: a review[J]. JAMA, 2020, 324(19): 1980-1991. DOI: 10.1001/jama.2020.17598.
|
| [4] |
Feifer AH, Taylor JM, Tarin TV, et al. Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy[J]. Eur Urol, 2011, 59(6): 978-984. DOI: 10.1016/j.eururo.2011.01.014.
|
| [5] |
Witjes JA, Bruins HM, Cathomas R, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines[J]. Eur Urol, 2021, 79(1): 82-104. DOI: 10.1016/j.eururo.2020.03.055.
|
| [6] |
Kakizoe T. Orthotopic neobladder after cystectomy for bladder cancer[J]. Proc Jpn Acad Ser B Phys Biol Sci, 2020, 96(7): 255-265. DOI: 10.2183/pjab.96.019.
|
| [7] |
Lee RK, Abol-Enein H, Artibani W, et al. Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes[J]. BJU Int, 2014, 113(1): 11-23. DOI: 10.1111/bju.12121.
|
| [8] |
Leonardo K, Mirza H, Seno DH, et al. Transperitoneal vs extraperitoneal radical cystectomy: a systematic review and meta-analysis[J]. PLoS One, 2023, 18(11): e0294809. DOI: 10.1371/journal.pone.0294809.
|
| [9] |
Zhang Y, Zhou H, Tuo ZT, et al. Extraperitoneal laparoscopic radical cystectomy with intracorporeal neobladder: a comparison with transperitoneal approach[J]. World J Surg Oncol, 2022, 20(1): 130. DOI: 10.1186/s12957-022-02587-1.
|
| [10] |
Katsimperis S, Tzelves L, Tandogdu Z, et al. Complications after radical cystectomy: a systematic review and meta-analysis of randomized controlled trials with a meta-regression analysis[J]. Eur Urol Focus, 2023, 9(6): 920-929. DOI: 10.1016/j.euf.2023.05.002.
|
| [11] |
Kulkarni JN, Gulla RI, Tongaonkar HB, et al. Radical cystoprostatectomy: an extraperitoneal retrograde approach[J]. J Urol, 1999, 161(2): 545-548. DOI: 10.1016/s0022-5347(01)61946-3.
|
| [12] |
Shimizu F, Muto S, Kitamura K, et al. Robot-assisted radical cystectomy with modified vesica ileale padovana (VIP) neobladder configuration using a hybrid approach: initial experience[J]. J Pers Med, 2023, 13(5): 802. DOI: 10.3390/jpm13050802.
|
| [13] |
Matsumoto K, Tabata KI, Hirayama T, et al. Robot-assisted laparoscopic radical cystectomy is a safe and effective procedure for patients with bladder cancer compared to laparoscopic and open surgery: Perioperative outcomes of a single-center experience[J]. Asian J Surg, 2019, 42(1): 189-196. DOI: 10.1016/j.asjsur.2017.11.002.
|
| [14] |
Aminoltejari K, Hird AE, Klaassen Z, et al. Robotic versus open cystectomy for bladder cancer: synthesizing the data from current systematic reviews and meta-analyses[J]. Ann Surg Oncol, 2023, 30(5): 2976-2987. DOI: 10.1245/s10434-022-12692-w.
|
| [15] |
关有彦, 邢念增, 寿建忠,等. 全球泌尿系统常见恶性肿瘤流行病学情况及我国现状分析[C]//2019中国肿瘤学大会.重庆:2019.
|
| [16] |
Woldu SL, Bagrodia A, Lotan Y. Guideline of guidelines: non-muscle-invasive bladder cancer[J]. BJU Int, 2017, 119(3): 371-380. DOI: 10.1111/bju.13760.
|
| [17] |
Sylvester RJ, Oosterlinck W, Holmang S, et al. Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection with transurethral resection alone in patients with stage pTa-PT1 urothelial carcinoma of the bladder: which patients benefit from the instillation?[J]. Eur Urol, 2016, 69(2): 231-244. DOI: 10.1016/j.eururo.2015.05.050.
|
| [18] |
Malmström PU, Rintala E, Wahlqvist R, et al. Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group[J]. J Urol, 1996, 155(6): 1903-1906.
|
| [19] |
Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020[J]. CA Cancer J Clin, 2020, 70(5): 404-423. DOI: 10.3322/caac.21631.
|
| [20] |
Yang LS, Shan BL, Shan LL, et al. A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer[J]. Surg Oncol, 2016, 25(3): 281-297. DOI: 10.1016/j.suronc.2016.05.027.
|
| [21] |
Lawrentschuk N, Colombo R, Hakenberg OW, et al. Prevention and management of complications following radical cystectomy for bladder cancer[J]. Eur Urol, 2010, 57(6): 983-1001. DOI: 10.1016/j.eururo.2010.02.024.
|
| [22] |
Menon M, Hemal AK, Tewari A, et al. Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion[J]. BJU Int, 2003, 92(3): 232-236. DOI: 10.1046/j.1464-410x.2003.04329.x.
|
| [23] |
Cai PY, Khan AI, Shoag JE, et al. Robotic radical cystectomy in the contemporary management of bladder cancer[J]. Urol Clin North Am, 2021, 48(1): 45-50. DOI: 10.1016/j.ucl.2020.09.003.
|
| [24] |
Parekh DJ, Reis IM, Castle EP, et al. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial[J]. Lancet, 2018, 391(10139): 2525-2536. DOI: 10.1016/S0140-6736(18)30996-6.
|